Combined therapy with proton pump inhibitors and clopidogrel – focus on cardiovascular risk
Aim. To analyze accessible studies on the problem of potential interaction of proton pump inhibitors and clopidogrel and to evaluate the influence of combined therapy with these pharmacologic agents on cardiovascular adverse effects development. Materials and methods. Data from 43 foreign and Russi...
Main Authors: | Aleksei I. Kochetkov, Olga D. Ostroumova, Evgenii V. Kravchenko, Olga V. Bondarets, Tatiana F. Guseva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ZAO "Consilium Medicum"
2019-01-01
|
Series: | Consilium Medicum |
Subjects: | |
Online Access: | http://consilium.orscience.ru/en/archive/2019/vol-21-1-2019/combined-therapy-with-proton-pump-inhibitors-and-clopidogrel-focus-on-cardiovascular-risk-_5092/?element |
Similar Items
-
Modifying effect of diabetes on the short-term effect of clopidogrel in patients with myocardial infarction
by: Wuxiang Xie, et al.
Published: (2018-01-01) -
Interaction between proton pump inhibitors and clopidogrel
by: Oyetayo, Olaonipekun Oladoyin
Published: (2011) -
СONCOMITANT ADMINISTRATION OF CLOPIDOGREL AND PROTON PUMP INHIBITORS: ARE THERE ANY OPEN QUESTIONS LEFT TODAY?
by: S. Yu. Martsevich, et al.
Published: (2015-09-01) -
Clopidogrel in cardiovascular disease treatment: modern clinical recommendations
by: I. S. Yavelov
Published: (2006-10-01) -
Effect of original and generic clopidogrel on prognosis in relation to different gene polymorphisms
by: D F Mesitskaia, et al.
Published: (2014-09-01)